Marsh & McLennan Companies (MMC)
(Delayed Data from NYSE)
$201.73 USD
+4.11 (2.08%)
Updated Apr 18, 2024 04:00 PM ET
After-Market: $201.73 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$201.73 USD
+4.11 (2.08%)
Updated Apr 18, 2024 04:00 PM ET
After-Market: $201.73 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
Zacks News
What's in the Cards for Willis Towers (WLTW) in Q3 Earnings?
by Zacks Equity Research
Willis Towers (WLTW) Q3 earnings are likely to have benefited from higher commissions, net new business, and favorable renewals. However, revenues may have been under pressure due to the COVID-19 pandemic.
Marsh & McLennan (MMC) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Marsh & McLennan (MMC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
eHealth (EHTH) to Report Q3 Earnings: Is a Beat in Store?
by Zacks Equity Research
eHealth's (EHTH) Q3 results are likely to benefit from solid performance at Medicare and individual and family plan business.
Why Should You Retain Marsh & McLennan in Your Portfolio?
by Zacks Equity Research
Owing to strategic measures and an encouraging solvency position, Marsh & McLennan (MMC) holds enough promises for investors' portfolio.
Marsh & McLennan's (MMC) Arm Ties Up With Triterras Fintech
by Zacks Equity Research
Marsh & McLennan's (MMC) Marsh arm forges an alliance with Triterras Fintech to provide customers with a digitized access to credit insurance.
MMC vs. AJG: Which Insurance Brokerage Stock Should You Hold?
by Zacks Equity Research
Marsh & McLennan (MMC) and Arthur J. Gallagher (AJG) are poised to grow in the thriving insurance brokerage space. Through comparisons, we discover which stock is stronger, based on the fundamentals.
Marsh & McLennan (MMC): Strong Industry, Solid Earnings Estimate Revisions
by Zacks Equity Research
Marsh & McLennan (MMC) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Brown & Brown Inks Deal to Acquire VAS-Affiliated Companies
by Zacks Equity Research
Brown & Brown (BRO) agrees to the acquisition of VAS-affiliated companies to provide its collective customers with innovative solutions.
Marsh & McLennan's Unit Surpasses $1 Billion Mark in AUM
by Zacks Equity Research
Marsh & McLennan's (MMC) business Mercer crosses the $1 billion mark in assets under management or AUM.
Why Is Marsh & McLennan (MMC) Down 2.3% Since Last Earnings Report?
by Zacks Equity Research
Marsh & McLennan (MMC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why You Should Hold Marsh & McLennan (MMC) in Your Portfolio
by Zacks Equity Research
Riding high on strategic measures and operating efficiency, Marsh & McLennan (MMC) holds potential to reap benefits for investors.
Brown & Brown's Subsidiary Buys Assets of Amity Insurance
by Zacks Equity Research
Brown & Brown's (BRO) subsidiary Brown & Brown of Massachusetts acquires Amity Insurance Agency to add more teammates to its operations in New England.
Brown & Brown's Unit Acquires Assets of Buiten & Associates
by Zacks Equity Research
Brown & Brown's (BRO) subsidiary Brown & Brown of Michigan acquires Buiten & Associates to reinforce its presence in Michigan.
Brown & Brown (BRO) Inks Deal to Acquire Assets of HAUSER
by Zacks Equity Research
Brown & Brown (BRO) agrees to the acquisition of the assets of HAUSER to aid collective customers.
Zacks Industry Outlook Highlights: eHealth, Brown & Brown, Arthur J. Gallagher and Marsh & McLennan Companies
by Zacks Equity Research
Zacks Industry Outlook Highlights: eHealth, Brown & Brown, Arthur J. Gallagher and Marsh & McLennan Companies
Bright Near-Term Prospects for Insurance Brokerage Industry
by Tanuka De
Insurance - Brokerage Industry is poised for growth given growing demand for insurance even amid the pandemic.
What Awaits American International's (AIG) Earnings in Q2?
by Zacks Equity Research
American International (AIG) Q2 earnings performance is likely to have suffered COIVD-19-related business disruption and lower investment income.
Marsh & McLennan's (MMC) Earnings Beat in Q2, Improve Y/Y
by Zacks Equity Research
Marsh & McLennan's (MMC) Q2 results reflect lower expenses and an impressive performance by its Risk and Insurance Services segment.
Marsh & McLennan (MMC) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Marsh & McLennan (MMC) delivered earnings and revenue surprises of 15.79% and 0.51%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Will Lower Revenues Impair Nokia's (NOK) Earnings in Q2?
by Zacks Equity Research
Nokia's (NOK) second-quarter performance is expected to have been significantly impacted by the COVID-19 pandemic.
Why the Earnings Surprise Streak Could Continue for Marsh & McLennan (MMC)
by Zacks Equity Research
Marsh & McLennan (MMC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
What Awaits Willis Towers Watson (WLTW) in Q2 Earnings?
by Zacks Equity Research
Willis Towers (WLTW) Q2 earnings are likely to have benefited from higher organic commissions and fees and solid customer retention though revenues may have been under pressure due to the pandemic.
Marsh & McLennan (MMC) to Report Q2 Earnings: What to Expect
by Zacks Equity Research
Marsh & McLennan's (MMC) second-quarter earnings are likely to have been affected by weak revenues.
What's in Store for Arthur J. Gallagher (AJG) in Q2 Earnings?
by Zacks Equity Research
Arthur J. Gallagher's (AJG) Q2 results are likely to reflect new business production, strategic buyouts, and organic revenue growth.
Aon (AON) Gears Up to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
Aon's (AON) second-quarter 2020 results are likely to have been impacted by soft revenues at most of the segments except Reinsurance Solutions, partly offset by lower expenses.